Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trialDouglas R. Adkins, Peter Oppelt, William C. Spanos et al.|Oral Oncology|2021Cited by 31
Multicenter Phase 2 Trial of C is/Carboplatin, nAb -Paclitaxel, and C e TUX imab ( CACTUX ) as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaDouglas R. Adkins, Peter Oppelt, Jessica Ley et al.|International Journal of Radiation Oncology*Biology*Physics|2018Cited by 9